Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Achilles Therapeutics plc - American Depositary Shares
(NQ:
ACHL
)
1.480
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.480
Bid (Size)
1.470 (1)
Ask (Size)
1.480 (560)
Prev. Close
1.480
Today's Range
1.480 - 1.480
52wk Range
0.9220 - 1.510
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
These stocks have an unusual volume in today's session
February 11, 2025
Unusual volume stocks in Tuesday's session
Via
Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look.
February 06, 2025
Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
Performance
YTD
+29.8%
+29.8%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+49.5%
+49.5%
More News
Read More
These stocks have an unusual volume in today's session
February 05, 2025
Via
Chartmill
Discover the top movers in Tuesday's pre-market session.
February 04, 2025
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 04, 2025
Via
Benzinga
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
December 24, 2024
Via
Benzinga
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
September 19, 2024
Via
Benzinga
ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
May 22, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 08, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
April 04, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via
Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
Via
Benzinga
Topics
Stocks
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Via
Benzinga
ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023
April 04, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
Via
InvestorPlace
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
April 04, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
April 04, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
February 05, 2024
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
December 18, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
November 13, 2023
From
Achilles Therapeutics PLC
Via
GlobeNewswire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
Investor Brand Network
Frequently Asked Questions
Is Achilles Therapeutics plc - American Depositary Shares publicly traded?
Yes, Achilles Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Achilles Therapeutics plc - American Depositary Shares trade on?
Achilles Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Achilles Therapeutics plc - American Depositary Shares?
The ticker symbol for Achilles Therapeutics plc - American Depositary Shares is ACHL on the Nasdaq Stock Market
What is the current price of Achilles Therapeutics plc - American Depositary Shares?
The current price of Achilles Therapeutics plc - American Depositary Shares is 1.480
When was Achilles Therapeutics plc - American Depositary Shares last traded?
The last trade of Achilles Therapeutics plc - American Depositary Shares was at 03/20/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.